ROCKWELL MEDICAL INC
RMTINASDAQ🏆 #3523 by market capUS Equity
$468.94▲ $5.81 (+1.24%)
Simulated price1h—
24h▲ 1.2%
7d▲ 6306.3%
14d▲ 6297.5%
30d▲ 8259.0%
1y▲ 4661.3%
🏦Market Cap
$27M
Small Cap
📈Revenue Growth (YoY)
-30.8%
Declining
📊Gross Margin
18.1%
Thin
💵FCF Margin
5.7%
Moderate
⚖️P/S Ratio
0.4x
Cheap
Otter Score
60
Fair
Trading Snapshot
- Day Range
- $467.53 – $476.74
- 52-Week Range
- $4.89 – $21.00
- Volume
- $6.77B
- Avg Volume
- $5.45B
- Shares Outstanding
- 4.0M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $67M
- Last Q Revenue
- $16M
- P/E Ratio
- —
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-0.15
- Dividend Yield
- —
Why Investors Own RMTI
- ✓High-growth profile — revenue up +12.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 75% gross margin and 10% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$67M▲ +10.4% YoY
Gross Margin (TTM)
75.2%▲ +0.0% YoY
Operating Income (TTM)
$17M▲ +10.4% YoY
Free Cash Flow (TTM)
$7M▲ +10.4% YoY
About ROCKWELL MEDICAL INC
A company profile for ROCKWELL MEDICAL INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
60/100
Analyst Price Target
ⓘAverage Target
$585.98
▲ +25.0% Upside
High Target$688.46
Low Target$498.53
Based on 30 analysts
Latest News & Updates
🚀
Barron’s·2h ago
ROCKWELL MEDICAL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift RMTI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
ROCKWELL MEDICAL INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.